Georges Dagher has built a career at the intersection of science, strategy, and healthcare access, shaping how medicines move from discovery to delivery. With deep expertise across global markets, he champions value-driven commercialization, market access by design, and cross-functional leadership, ensuring innovation reaches patients faster, more effectively, and with lasting systemic impact.
The radical transformation in the structure of value characterizes the world of pharmaceuticals in 2026. We see that the age when quick advances in the field of science were evaluated on their intrinsic values is
